Important notification
29.08.2025 To the attention of all interested parties According to the information obtained by the NAMMDR, counterfeit medical devices originating […]
Press release
26.08.2025 To the attention of interested persons Information regarding the misuse of the name of the National Agency for Medicines […]
Summary of field safety notifications / JULY 2025
SUMMARY OF FIELD SAFETY NOTIFICATIONS / JULY 2025 USER INFORMATION BIOFIRE® Blood Culture Identification 2 (BCID2) Panel / manufacturer BioFire […]
Press release
01.08.2025 To the attention of interested persons Rybelsus: Risk of medication error due to new tablet formulation download document …
Important notification
04.08.2025 To the attention of all interested parties The NAMMDR was informed about the presence on the territory of Portugal […]
Important notification
01.08.2025 To the attention of all interested persons The NAMMDR warns of the withdrawal of the EC certification for Los […]
Important notification
31.07.2025 To the attention of Romanian manufacturers of medical devices and in vitro diagnostic medical devices and all interested parties […]
Press release
25.07.2025 To the attention of interested persons First reformulation of an inhaled medicine with environmentally friendly gas propellant download document […]
Press release
25.07.2025 To the attention of interested persons New treatment for Niemann-Pick type C disease; Aqneursa significantly improves neurological signs, symptoms […]
Press release
11.07.2025 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7 – 10 July […]